BKV Large T antigen 579-587 (HLA-A*02:01)
€57.50 *
Prices plus VAT plus shipping costs
Delivery time 3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
- Order number: EP11093_1
BKV LT-ag peptide LLLIWFRPV (HLA-A*02:01) for stimulation of human BKV LT-ag(579-587)-specific... more
Product information "BKV Large T antigen 579-587 (HLA-A*02:01)"
BKV LT-ag peptide LLLIWFRPV (HLA-A*02:01) for stimulation of human BKV LT-ag(579-587)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. LLLIWFRPV is a linear peptidic epitope (epitope ID37507) studied as part of Human polyomavirus 1 (polyomavirus BK) protein from Human polyomavirus 1 (BK polyomavirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assay.
Available downloads:
####
Sequence: | LLLIWFRPV | |
Gene: | N/A | |
Delivery: | 3 weeks | |
C-Terminus: | OH | |
N-Terminus: | H | |
Purity: | 95% | |
Amount: | 1 mg | |
Counter Ion: | TFA | |
Protein: | Large T antigen | |
Species: | BK polyomavirus (BKPyV) (Human polyomavirus 1) | |
Allele: | HLA-A*02:01 | |
Application : | Flow Cytometry Immunohistochemistry | |
Indication : | AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 |
Dokumente - Protokolle - Downloads more
Protocols and Tips
Data sheets
Viewed